This scholar award program provided funding and strategic advisory services to physician-scientists at the University of Oxford. It ran from 2014-2016 and has been replaced by a national UK rare disease program launched in January 2020.
- Two-year grant
- Funding up to £60K
- Drug development expertise and project management support
- Expert business, commercialization, and clinical development advice
- Regulatory assistance
- Intellectual property (IP) review and advice
- Assistance identifying and securing additional financial support based on project needs